Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1148020140390030120
Á¶¼±´ëÇб³ÀÇ´ë³í¹®Áý
2014 Volume.39 No. 3 p.120 ~ p.125
Treatment Efficacy of Tenofovir in Korean Patients with Chronic Hepatitis B after Twelve Months of Treatment
Ju Jong-Seok

Kang Sung-Hoon
Kim Seok-Won
Shin Hae-Jin
Lee Eaum-Seok
Kim Seok-Hyun
Lee Byung-Seok
Lee Heon-Young
Abstract
The aim of this study was to evaluate the efficacy of tenofovir in HBV patients at 12 months after treatment. A total of 122
chronic hepatitis B patients who took tenofovir for at least 12 months were enrolled. We measured ALT levels, HBeAg, anti-
HBe, HBV DNA, and serum creatinine at six and 12 months after treatment. The virological response rate at six and 12
months after treatment in naive patients was 27.1% and 41.7%, respectively. High virological response rate at six and 12
months after treatment showed an association with initial low HBV DNA titer and initial negative HBeAg status.
KEYWORD
Chronic Hepatitis B, Tenofovir
FullTexts / Linksout information
Listed journal information